AcouSort AB (publ) (STO:ACOU)

Sweden flag Sweden · Delayed Price · Currency is SEK
3.930
-0.070 (-1.75%)
Apr 28, 2026, 2:09 PM CET
4.52%
Market Cap 83.17M
Revenue (ttm) 10.43M
Net Income (ttm) -12.15M
Shares Out 21.16M
EPS (ttm) -0.64
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,170
Average Volume 49,295
Open 3.930
Previous Close 4.000
Day's Range 3.640 - 3.940
52-Week Range 2.030 - 4.480
Beta -0.12
RSI 66.96
Earnings Date May 22, 2026

About AcouSort AB

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrumen... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 16
Stock Exchange Nasdaq Stockholm
Ticker Symbol ACOU
Full Company Profile

Financial Performance

In 2025, AcouSort AB's revenue was 10.43 million, an increase of 4.01% compared to the previous year's 10.03 million. Losses were -12.15 million, -19.40% less than in 2024.

Financial Statements

News

AcouSort AB Transcript: Status Update

AcouSort targets high-growth markets with its automated sample preparation technology, validated in commercial systems and supported by OEM and research partnerships. Active collaborations and product innovation drive recurring revenue potential, with funding secured through 2026.

1 year ago - Transcripts